InsiderTrades.com logo
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin

ABIO Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 30.90%
Insider Buying (Last 12 Months): $1,666,176.48
Insider Selling (Last 12 Months): $0.00

ARCA biopharma Insider Trading History Chart

This chart shows the insider buying and selling history at ARCA biopharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ARCA biopharma Share Price & Price History

Current Price: $0.00
Price Change: +0.30 (1.20%)
As of 08/30/2024 09:53 PM ET

This chart shows the closing price history over time for ABIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

ARCA biopharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/16/2024Henderson Group Plc JanusMajor ShareholderBuy40$421.92$16,876.8014,702View SEC Filing Icon  
7/24/2024Henderson Group Plc JanusMajor ShareholderBuy1,318$460.80$607,334.4014,452View SEC Filing Icon  
7/10/2024Henderson Group Plc JanusMajor ShareholderBuy385$498.24$191,822.4012,477View SEC Filing Icon  
7/8/2024Henderson Group Plc JanusMajor ShareholderBuy329$498.24$163,920.9611,974View SEC Filing Icon  
7/5/2024Henderson Group Plc JanusMajor ShareholderBuy196$493.92$96,808.3211,645View SEC Filing Icon  
7/3/2024Henderson Group Plc JanusMajor ShareholderBuy1,153$511.20$589,413.6011,448View SEC Filing Icon  
5/25/2022Fund Lp FunicularInsiderBuy450$334.08$150,336.0017,919View SEC Filing Icon  
5/23/2022Fund Lp FunicularInsiderBuy15$329.76$4,946.4017,343View SEC Filing Icon  
5/18/2022Fund Lp FunicularInsiderBuy90$331.20$29,808.0017,327View SEC Filing Icon  
5/16/2022Fund Lp FunicularInsiderBuy298$331.20$98,697.6017,236View SEC Filing Icon  
5/13/2022Fund Lp FunicularInsiderBuy97$329.76$31,986.7216,938View SEC Filing Icon  
5/11/2022Fund Lp FunicularInsiderBuy170$329.76$56,059.2016,647View SEC Filing Icon  
5/9/2022Fund Lp FunicularInsiderBuy341$326.88$111,466.0816,331View SEC Filing Icon  
5/5/2022Fund Lp FunicularInsiderBuy117$326.88$38,244.9615,586View SEC Filing Icon  
5/2/2022Fund Lp FunicularInsiderBuy8$332.64$2,661.1215,469View SEC Filing Icon  
4/28/2022Fund Lp FunicularInsiderBuy162$334.08$54,120.9615,398View SEC Filing Icon  
4/25/2022Fund Lp FunicularInsiderBuy95$329.76$31,327.2015,235View SEC Filing Icon  
4/18/2022Fund Lp FunicularInsiderBuy63$332.64$20,956.3215,140View SEC Filing Icon  
4/14/2022Fund Lp FunicularInsiderBuy120$335.52$40,262.4015,077View SEC Filing Icon  
4/11/2022Fund Lp FunicularInsiderBuy32$332.64$10,644.4814,474View SEC Filing Icon  
4/8/2022Fund Lp FunicularInsiderBuy212$332.64$70,519.6814,441View SEC Filing Icon  
4/6/2022Fund Lp FunicularInsiderBuy186$331.20$61,603.20View SEC Filing Icon  
4/4/2022Fund Lp FunicularInsiderBuy849$325.44$276,298.5614,229View SEC Filing Icon  
11/22/2021Christopher David OzeroffVPBuy347$325.44$112,927.68View SEC Filing Icon  
See Full Table
Breaking News: Tesla headed to $500…
From WealthPress   |   Ad
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
So to claim your free digital copy today, simply follow this link and enter your email address. 

SEC Filings (Institutional Ownership Changes) for ARCA biopharma (NASDAQ:ABIO)

56.44% of ARCA biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ABIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

ARCA biopharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/16/2024Cubist Systematic Strategies LLC27,779$0.11M0.0%N/A0.191%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC15,507,760$59.40M1.4%N/A106.898%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC3,846,150$14.73M0.1%N/A26.512%Search for SEC Filing on Google Icon
8/15/2024Affinity Asset Advisors LLC72,484$0.28M0.0%N/A0.500%Search for SEC Filing on Google Icon
8/14/2024Cubist Systematic Strategies LLC27,779$0.11M0.0%N/A0.191%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC73,099$0.28M0.0%+11.3%0.504%Search for SEC Filing on Google Icon
8/7/2024Cowen AND Company LLC700,000$2.68M0.1%N/A4.825%Search for SEC Filing on Google Icon
2/20/2024Cable Car Capital LLC4,000,452$6.80M7.6%N/A27.589%Search for SEC Filing on Google Icon
1/31/2024abrdn plc32,461$55K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/14/2023Newtyn Management LLC300,000$0.60M0.1%-4.2%0.000%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC706,930$1.41M1.2%-17.6%0.000%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC858,256$2.03M1.9%N/A5.956%Search for SEC Filing on Google Icon
2/10/2023Murchinson Ltd.50,593$0.12M0.0%N/A0.351%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC14,221$29K0.0%N/A0.099%Search for SEC Filing on Google Icon
7/27/2022Bailard Inc.35,000$87K0.0%N/A0.243%Search for SEC Filing on Google Icon
4/26/2022Marquette Asset Management LLC17,318$40K0.0%N/A0.120%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC57,822$0.12M0.0%N/A0.401%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP441,945$1.31M0.1%+238.9%3.067%Search for SEC Filing on Google Icon
11/15/2021Minerva Advisors LLC10,000$30K0.0%N/A0.069%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.268,394$0.80M0.0%-1.8%1.863%Search for SEC Filing on Google Icon
8/16/2021State Street Corp69,037$0.24M0.0%N/A0.479%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC87,659$0.31M0.0%+10.7%0.608%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.398,507$1.39M0.0%+189.8%2.765%Search for SEC Filing on Google Icon
8/12/2021XTX Topco Ltd10,846$38K0.0%N/A0.075%Search for SEC Filing on Google Icon
8/5/2021GSA Capital Partners LLP130,395$0.46M0.1%+39.8%0.905%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC16,655$61K0.0%-32.4%0.116%Search for SEC Filing on Google Icon
5/17/2021PDT Partners LLC17,297$63K0.0%N/A0.120%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC79,151$0.29M0.0%+141.7%0.549%Search for SEC Filing on Google Icon
5/10/2021GSA Capital Partners LLP93,241$0.34M0.1%+102.3%0.647%Search for SEC Filing on Google Icon
2/24/2021Virtu Financial LLC24,641$99K0.0%N/A0.264%Search for SEC Filing on Google Icon
2/10/2021Renaissance Technologies LLC205,500$0.82M0.0%+436.4%2.205%Search for SEC Filing on Google Icon
2/10/2021Panagora Asset Management Inc.6,878$28K0.0%N/A0.074%Search for SEC Filing on Google Icon
2/4/2021GSA Capital Partners LLP46,097$0.19M0.0%N/A0.495%Search for SEC Filing on Google Icon
11/19/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/17/2020Schonfeld Strategic Advisors LLC18,200$80K0.0%N/A0.195%Search for SEC Filing on Google Icon
11/6/2020BlackRock Inc.287,263$1.27M0.0%+598,364.6%4.865%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
ARCA biopharma logo
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
Read More on ARCA biopharma

Today's Range

Now: N/A

50 Day Range

MA: $384.99
Low: $2.40
High: $599.04

52 Week Range

Now: N/A

Volume

290,800 shs

Average Volume

607,995 shs

Market Capitalization

$34.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.91

Who are the company insiders with the largest holdings of ARCA biopharma?

ARCA biopharma's top insider investors include:
  1. Henderson Group Plc Janus (Major Shareholder)
Learn More about top insider investors at ARCA biopharma.
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
From Crypto Swap Profits   |   Ad
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
Register for the FREE Workshop Now & get $10 in Bitcoin